Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block for Pain Management in Hip Arthroplasty
NCT06916000Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Pain assessment using a Numeric Rating System (NRS) at 24 hours. Started Jun 2024; status: active, not recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06916000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06916000.